<DOC>
	<DOCNO>NCT02226315</DOCNO>
	<brief_summary>This study evaluate clinical performance massively parallel sequencing ( MPS ) use MaterniT21 PLUS LDT detection fetal aneuploidy circulate cfDNA extract maternal blood sample obtain woman pregnant multiple gestation increase risk fetal aneuploidy .</brief_summary>
	<brief_title>Clinical Performance MaterniT21 PLUS LDT Multiple Gestation Pregnancies</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Down Syndrome</mesh_term>
	<mesh_term>Turner Syndrome</mesh_term>
	<mesh_term>Gonadal Dysgenesis</mesh_term>
	<mesh_term>Primary Ovarian Insufficiency</mesh_term>
	<criteria>Subject pregnant multiple gestation receive NIPT MaterniT21 PLUS LDT valid test result available ; Subject 18 year age old time NIPT ; Subject provide sign date informed consent English ; Subjects ' treat physician locate United States .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>noninvasive prenatal test</keyword>
</DOC>